Woojin Kang, Ph.D. - Publications

Affiliations: 
2009 Florida State University, Tallahassee, FL, United States 
Area:
General

274 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Kang WK, Han DG, Kim SE, Lee YJ, Shim JS. Bone remodeling after conservative treatment of nasal bone fracture in pediatric patients. Archives of Craniofacial Surgery. 21: 166-170. PMID 32630988 DOI: 10.7181/acfs.2020.00192  0.76
2020 Kim ST, Hong JY, Park SH, Park JO, Park YW, Park N, Lee H, Hong SH, Lee SJ, Song SW, Kim K, Park YS, Lim HY, Kang WK, Nam DH, et al. First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients. Therapeutic Advances in Medical Oncology. 12: 1758835920926796. PMID 32536979 DOI: 10.1177/1758835920926796  0.92
2020 Lee SJ, Hong JY, Kim K, Kim KM, Kang SY, Lee T, Kim ST, Park SH, Park YS, Lim HY, Kang WK, Lee J, Park JO. Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare Cancers. Journal of Oncology. 2020: 4659062. PMID 32411236 DOI: 10.1155/2020/4659062  0.92
2020 Kim J, Byeon S, Kim H, Yeo JH, Hong JY, Lee J, Lim HY, Kang WK, Kim ST. Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint Inhibitors in Advanced Gastric Cancer Patients. Targeted Oncology. PMID 32314267 DOI: 10.1007/s11523-020-00713-1  1
2020 Yu JI, Park HC, Lee J, Choi C, Kang WK, Park SH, Kim ST, Sohn TS, Lee JH, An JY, Choi MG, Bae JM, Kim KM, Han H, Kim K, et al. Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer. Cancers. 12. PMID 32290335 DOI: 10.3390/cancers12040943  0.92
2020 Choi S, Jang J, Heo YJ, Kang SY, Kim ST, Lee J, Kang WK, Kim JW, Kim KM. CDH1 mutations in gastric cancers are not associated with family history. Pathology, Research and Practice. 152941. PMID 32241597 DOI: 10.1016/j.prp.2020.152941  0.92
2020 Kim J, Hong JY, Kim ST, Park SH, Jekal SY, Choi JS, Chang DK, Kang WK, Seo SW, Lee J. Clinical scoring system for the prediction of survival of patients with advanced gastric cancer. Esmo Open. 5. PMID 32188716 DOI: 10.1136/esmoopen-2020-000670  1
2020 Byeon S, Hong JY, Lee J, Nam DH, Park SH, Park JO, Park YS, Lim HY, Kang WK, Kim ST. Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study. Targeted Oncology. PMID 32107712 DOI: 10.1007/s11523-020-00706-0  0.92
2020 Hong JY, Kim HJ, Kim K, Hong J, Kim JE, Byeon SJ, Lee IK, Kim KM, Shim M, Park SH, Park JO, Park YS, Lim HY, Kim ST, Lee J, ... Kang WK, et al. TPK1 as a predictive marker for the anti-tumour effects of simvastatin in gastric cancer. Pathology, Research and Practice. 152820. PMID 31964553 DOI: 10.1016/j.prp.2020.152820  0.92
2020 Shin E, Lim DH, Han J, Nam DH, Park K, Ahn MJ, Kang WK, Lee J, Ahn JS, Lee SH, Sun JM, Jung HA, Chung TY. Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors. Bmc Ophthalmology. 20: 19. PMID 31918686 DOI: 10.1186/s12886-019-1285-9  0.92
2019 Chen LT, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, et al. A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 31863227 DOI: 10.1007/s10120-019-01034-7  0.88
2019 Kim HK, Lee I, Kim ST, Lee J, Kim KM, Park JO, Kang WK. RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis. Scientific Reports. 9: 19439. PMID 31857616 DOI: 10.1038/s41598-019-55767-7  0.92
2019 Lim SH, Sa JK, Lee DW, Kim J, Kim ST, Park SH, Ku B, Park JO, Park YS, Lim H, Kang WK, Nam DH, Lee J. Systematic Evaluation of Gastric Tumor Cell Index and Two-Drug Combination Therapy via 3-Dimensional High-Throughput Drug Screening. Frontiers in Oncology. 9: 1327. PMID 31850215 DOI: 10.3389/fonc.2019.01327  1
2019 Kim ST, Hong JY, Lee J, Park JO, Lim HY, Kang WK, Park YS. Pemetrexed/Erlotinib as a Salvage Treatment in Patients with High EGFR-Expressing Metastatic Colorectal Cancer Following Failure of Standard Chemotherapy: A Phase II Single-Arm Prospective Study. Targeted Oncology. PMID 31820199 DOI: 10.1007/s11523-019-00691-z  0.92
2019 Yoo GS, Park HC, Yu JI, Choi DH, Cho WK, Park YS, Park JO, Lim HY, Kang WK, Lee WY, Kim HC, Yun SH, Cho YB, Park YA, Song KD, et al. Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 31588705 DOI: 10.4143/crt.2019.261  0.92
2019 Yu JI, Lim DH, Lee J, Kang WK, Park SH, Park JO, Lim HY, Kim ST, Kim S, Sohn TS, Lee JH, An JY, Choi MG, Bae JM, Kim HS, et al. Clinical Outcomes and the Role of Adjuvant Concurrent Chemoradiation Therapy in D2-resected LN-positive Young Patients (≤45 Years) With Gastric Cancer. Anticancer Research. 39: 5811-5820. PMID 31570486 DOI: 10.21873/anticanres.13785  0.92
2019 Pietrantonio F, Miceli R, Raimondi A, Kim YW, Kang WK, Langley RE, Choi YY, Kim KM, Nankivell MG, Morano F, Wotherspoon A, Valeri N, Kook MC, An JY, Grabsch HI, et al. Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901124. PMID 31513484 DOI: 10.1200/JCO.19.01124  0.92
2019 Kim HN, Jang J, Heo YJ, Kim B, Jung H, Jang Y, Kang SY, Kim ST, Lee J, Kang WK, Kim KM. PD-L1 expression in gastric cancer determined by digital image analyses: pitfalls and correlation with pathologist interpretation. Virchows Archiv : An International Journal of Pathology. PMID 31463730 DOI: 10.1007/s00428-019-02653-2  0.92
2019 Kwon D, Kim B, Shin HC, Kim EJ, Ha SY, Jang KT, Kim ST, Lee J, Kang WK, Park JO, Kim KM. Cancer Panel Assay for Precision Oncology Clinic: Results from a 1-Year Study. Translational Oncology. 12: 1488-1495. PMID 31442744 DOI: 10.1016/j.tranon.2019.07.017  0.92
2019 Lee J, Kim ST, Kim K, Lee H, Kozarewa I, Mortimer PG, Odegaard JI, Harrington EA, Lee J, Lee T, Oh SY, Kang JH, Kim JH, Kim Y, Ji JH, ... ... Kang WK, et al. Tumor genomic profiling guides metastatic gastric cancer patients to targeted treatment: The VIKTORY Umbrella Trial. Cancer Discovery. PMID 31315834 DOI: 10.1158/2159-8290.CD-19-0442  1
2019 Kim Y, Byeon SJ, Hur J, Lee K, Kim D, Ahn JH, Lee SH, You WK, Kim ST, Park SH, Kang WK, Kim KM, Lee J. High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancer. Journal of Cancer. 10: 3172-3178. PMID 31289587 DOI: 10.7150/jca.30257  0.96
2019 Yoon SE, Kim JH, Lee SJ, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS, Kim ST. The impact of primary tumor site on outcomes of treatment with etoposide and cisplatin in grade 3 gastroenteropancreatic neuroendocrine carcinoma. Journal of Cancer. 10: 3140-3144. PMID 31289584 DOI: 10.7150/jca.30355  0.92
2019 Lee SJ, Byeon SJ, Lee J, Park SH, Park JO, Park YS, Kang WK, Lim HY, Kim KM, Kim ST. LAG3 in Solid Tumors as a Potential Novel Immunotherapy Target. Journal of Immunotherapy (Hagerstown, Md. : 1997). PMID 31219974 DOI: 10.1097/CJI.0000000000000283  0.92
2019 Kim B, Shin HC, Heo YJ, Ha SY, Jang KT, Kim ST, Kang WK, Lee J, Kim KM. CCNE1 amplification is associated with liver metastasis in gastric carcinoma. Pathology, Research and Practice. 152434. PMID 31178228 DOI: 10.1016/j.prp.2019.152434  0.92
2019 Miceli R, An J, Di Bartolomeo M, Morano F, Kim ST, Park SH, Choi MG, Lee JH, Raimondi A, Fucà G, Sohn TS, Bae JM, Kim S, Lim DH, Kang WK, et al. Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial. Oncology. 1-6. PMID 31048579 DOI: 10.1159/000499628  0.92
2019 Choi S, Chu J, Kim B, Ha SY, Kim ST, Lee J, Kang WK, Han H, Sohn I, Kim KM. Tumor Heterogeneity Index to detect HER2 amplification by next-generation sequencing: A direct comparison study with immunohistochemistry. The Journal of Molecular Diagnostics : Jmd. PMID 31022472 DOI: 10.1016/j.jmoldx.2019.02.007  0.92
2019 Cho J, Ahn S, Son DS, Kim NK, Lee KW, Kim S, Lee J, Park SH, Park JO, Kang WK, An JY, Choi MG, Lee JH, Sohn TS, Bae JM, et al. Bridging Genomics and Phenomics of Gastric Carcinoma. International Journal of Cancer. PMID 30801717 DOI: 10.1002/ijc.32228  0.92
2019 Kim ST, Lee S, Park M, Park SH, Park JO, Lim HY, Park YS, Kang WK, Gangolli EA, Shin H, Kim KM, Hollingsworth SJ, Mortimer PGS, Lee J. Combination of Docetaxel Plus Savolitinib in Refractory Cancer Patients: A Report on Phase I Trial. Translational Oncology. 12: 597-601. PMID 30695737 DOI: 10.1016/j.tranon.2018.12.009  1
2019 Yoon SE, Lee SJ, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS, Kim ST. The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice. Oncotargets and Therapy. 12: 225-231. PMID 30636885 DOI: 10.2147/OTT.S187621  0.92
2018 Kim Y, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Lee SJ, Kim ST, Lee J, Park JO, Park YS, Lim HY, Kang WK, Park SH. Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial. Journal of Gastric Cancer. 18: 348-355. PMID 30607298 DOI: 10.5230/jgc.2018.18.e34  0.92
2018 Oh SY, Lee S, Huh SJ, Lee J, Kim ST, Park SH, Lim HY, Kang WK, Kang BW, Kim JG, Lee HJ, Kim JH, Kang JH, Kim H. Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancer. Cancer Chemotherapy and Pharmacology. PMID 30535535 DOI: 10.1007/s00280-018-3753-y  1
2018 Kim Y, Kim TW, Han SW, Ahn JB, Kim ST, Lee J, Park JO, Park YS, Lim HY, Kang WK. A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-Line Chemotherapy in Metastatic Colorectal Cancer Patients. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30477287 DOI: 10.4143/crt.2018.379  0.92
2018 Cho J, Kim KM, Kim HC, Lee WY, Kang WK, Park YS, Ha SY. The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma. Pathology, Research and Practice. PMID 30466765 DOI: 10.1016/j.prp.2018.10.024  0.92
2018 Sim J, Heo YJ, Bae H, Shin HC, Kim B, Cho J, Kim ST, Lee J, Kang WK, Kim KM. MET is overexpressed in microsatellite instability-high gastric carcinoma. Pathology, Research and Practice. PMID 30455128 DOI: 10.1016/j.prp.2018.11.010  0.92
2018 Yu JI, Lim DH, Lee J, Kang WK, Park SH, Park JO, Park YS, Lim HY, Kim ST, Lee SJ, Kim S, Sohn TS, Lee JH, An JY, Choi MG, et al. Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node‒Positive Gastric Cancer Treated with Different Adjuvant Protocols. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30282450 DOI: 10.4143/crt.2018.401  0.92
2018 Lee T, Kim K, Lee J, Park SH, Park YS, Lim HY, Kang WK, Park JO, Kim ST. Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation. Journal of Cancer. 9: 3394-3399. PMID 30271501 DOI: 10.7150/jca.26068  0.92
2018 Lim SW, Lee S, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK, Kim ST. Pemetrexed Monotherapy as Salvage Treatment in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy: A Phase II Single-arm Prospective Trial. Journal of Cancer. 9: 2910-2915. PMID 30123359 DOI: 10.7150/jca.24948  1
2018 Kim ST, Cristescu R, Bass AJ, Kim KM, Odegaard JI, Kim K, Liu XQ, Sher X, Jung H, Lee M, Lee S, Park SH, Park JO, Park YS, Lim HY, ... ... Kang WK, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nature Medicine. PMID 30013197 DOI: 10.1038/s41591-018-0101-z  1
2018 Kim ST, Kim HK, Lee J, Park SH, Lim HY, Park YS, Kang WK, Park JO. The impact of microsatellite instability status and sidedness of the primary tumor on the effect of bevacizumab-containing chemotherapy in patients with metastatic colorectal cancer. Journal of Cancer. 9: 1791-1796. PMID 29805705 DOI: 10.7150/jca.25132  0.92
2018 Oh SC, Sohn BH, Cheong JH, Kim SB, Lee JE, Park KC, Lee SH, Park JL, Park YY, Lee HS, Jang HJ, Park ES, Kim SC, Heo J, Chu IS, ... ... Kang WK, et al. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nature Communications. 9: 1777. PMID 29725014 DOI: 10.1038/s41467-018-04179-8  0.92
2018 Cho J, Chang YH, Heo YJ, Kim S, Kim NK, Park JO, Kang WK, Lee J, Kim KM. Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability. Esmo Open. 3: e000326. PMID 29636988 DOI: 10.1136/esmoopen-2018-000326  0.92
2018 Lee SJ, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS, Kim ST. c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival. Clinical Colorectal Cancer. PMID 29576428 DOI: 10.1016/j.clcc.2018.02.013  0.92
2018 Lee J, Kim ST, Park S, Lee S, Park SH, Park JO, Lim HY, Ahn H, Bok H, Kim KM, Ahn MJ, Kang WK, Park YS. Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer. Clinical Colorectal Cancer. PMID 29551559 DOI: 10.1016/j.clcc.2018.01.005  1
2018 Kim HK, Lee I, Bang H, Kim HC, Lee WY, Yun SH, Lee J, Lee SJ, Park YS, Kim KM, Kang WK. MCT4 Expression is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis. Molecular Cancer Therapeutics. PMID 29483215 DOI: 10.1158/1535-7163.MCT-17-0535  0.92
2018 Lee SJ, Kim JE, Kim ST, Lee J, Park SH, Park JO, Kang WK, Park YS, Lim HY. The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer. Translational Oncology. 11: 353-357. PMID 29448202 DOI: 10.1016/j.tranon.2018.01.007  0.92
2018 Kim ST, Banks KC, Pectasides E, Kim SY, Kim K, Lanman RB, Talasaz A, An J, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Park SH, Park JO, ... ... Kang WK, et al. Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2-positive gastric cancer patients. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29409051 DOI: 10.1093/annonc/mdy034  0.92
2018 Kim HS, Ryu MH, Zang DY, Park SR, Han B, Kang WK, Rha SY, Jung M, Kim JS, Kang BW, Lee KH, Rho SY, Kim JH, Kim KC, Cho JW, et al. Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 29372461 DOI: 10.1007/s10120-018-0794-1  0.84
2018 Kim SM, Min BH, Lee J, An JY, Lee JH, Sohn TS, Bae JM, Kim JJ, Kang WK, Kim S, Choi MG. Protective Effects of Female Reproductive Factors on Lauren Intestinal-Type Gastric Adenocarcinoma. Yonsei Medical Journal. 59: 28-34. PMID 29214773 DOI: 10.3349/ymj.2018.59.1.28  0.92
2017 Cho WK, Choi DH, Park HC, Park W, Yu JI, Park YS, Park JO, Lim HY, Kang WK, Kim HC, Cho YB, Yun SH, Lee WY. Elevated CEA is associated with worse survival in recurrent rectal cancer. Oncotarget. 8: 105936-105941. PMID 29285304 DOI: 10.18632/oncotarget.22511  0.92
2017 Kim JE, Kim Y, Li G, Kim ST, Kim K, Park SH, Park JO, Park YS, Lim HY, Lee H, Sohn TS, Kim KM, Kang WK, Lee J. MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines. Oncotarget. 8: 105727-105734. PMID 29285287 DOI: 10.18632/oncotarget.22394  0.92
2017 Yi JH, Jang J, Cho J, Do IG, Hong M, Kim ST, Kim KM, Lee S, Park SH, Park JO, Park YS, Kang WK, Lim HY, Lee J. MerTK is a novel therapeutic target in gastric cancer. Oncotarget. 8: 96656-96667. PMID 29228560 DOI: 10.18632/oncotarget.3750  1
2017 Kim ST, Klempner SJ, Park SH, Park JO, Park YS, Lim HY, Kang WK, Kim KM, Lee J. Correlating programmed death ligand 1 (PD-L1) expression, mismatch repair deficiency, and outcomes across tumor types: implications for immunotherapy. Oncotarget. 8: 77415-77423. PMID 29100397 DOI: 10.18632/oncotarget.20492  0.92
2017 Lee J, Cristescu R, Kim KM, Kim K, Kim ST, Park SH, Kang WK. Development of mesenchymal subtype gene signature for clinical application in gastric cancer. Oncotarget. 8: 66305-66315. PMID 29029513 DOI: 10.18632/oncotarget.19985  0.92
2017 Lee W, Yoo S, Jung J, Kang W, Wang W, Moon C, Choi H. All-in-one low-intensity pulsed ultrasound stimulation system using piezoelectric micromachined ultrasonic transducer (pMUT) arrays for targeted cell stimulation. Biomedical Microdevices. 19: 86. PMID 28929363 DOI: 10.1007/s10544-017-0228-6  0.32
2017 Kim ST, Lee SJ, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS. The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal Cancer. Journal of Cancer. 8: 2809-2815. PMID 28928870 DOI: 10.7150/jca.18286  0.92
2017 Kim JS, Kim JE, Kim K, Lee J, Park JO, Lim HY, Park YS, Kang WK, Kim ST. The Impact of Cetuximab Plus AKT- or mTOR- Inhibitor in a Patient-Derived Colon Cancer Cell Model with Wild-Type RAS and PIK3CA Mutation. Journal of Cancer. 8: 2713-2719. PMID 28928860 DOI: 10.7150/jca.19458  0.92
2017 Sohn BH, Hwang JE, Jang HJ, Lee HS, Oh SC, Shim JJ, Lee KW, Kim EH, Yim SY, Lee SH, Cheong JH, Jeong W, Cho JY, Kim J, Chae J, ... ... Kang WK, et al. Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28747339 DOI: 10.1158/1078-0432.CCR-16-2211  1
2017 Kim ST, Kim KM, Kim NKD, Park JO, Ahn S, Yun JW, Kim KT, Park SH, Park PJ, Kim HC, Sohn TS, Choi DI, Cho JH, Heo JS, Kwon W, ... ... Kang WK, et al. Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients; Utility of Targeted Deep Sequencing for Biomarker-Selected Clinical Trial. The Oncologist. PMID 28701572 DOI: 10.1634/theoncologist.2017-0020  0.92
2017 Jung KS, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK, Kim ST. Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer. Molecular and Clinical Oncology. 7: 27-31. PMID 28685070 DOI: 10.3892/mco.2017.1272  0.92
2017 Heo MH, Kim HK, Lee H, Kim KM, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS, Kim ST. The Clinical Impact of c-MET Over-Expression in Advanced Biliary Tract Cancer (BTC). Journal of Cancer. 8: 1395-1399. PMID 28638453 DOI: 10.7150/jca.17898  0.92
2017 Kim HK, Ha SY, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS, Kim ST. The impact of pathologic differentiation (well/poorly) and the degree of Ki-67 index in patients with metastatic WHO grade 3 GEP-NECs. Oncotarget. PMID 28598818 DOI: 10.18632/oncotarget.18168  0.92
2017 Ahn S, Brant R, Sharpe A, Dry JR, Hodgson DR, Kilgour E, Kim K, Kim ST, Park SH, Kang WK, Kim KM, Lee J. Correlation between MEK signature and Ras gene alteration in advanced gastric cancer. Oncotarget. PMID 28596502 DOI: 10.18632/oncotarget.18182  0.92
2017 Jang J, Kim HK, Bang H, Kim ST, Kim SY, Park SH, Lim HY, Kang WK, Lee J, Kim KM. Antitumor Effect of AZD4547 in a Fibroblast Growth Factor Receptor 2-Amplified Gastric Cancer Patient-Derived Cell Model. Translational Oncology. 10: 469-475. PMID 28501555 DOI: 10.1016/j.tranon.2017.03.001  0.92
2017 Cho M, Ahn S, Hong M, Bang H, Van Vrancken M, Kim S, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK, Sun JM, Lee SH, Ahn MJ, et al. Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences. Oncotarget. PMID 28477007 DOI: 10.18632/oncotarget.17199  1
2017 Lee SJ, Lee SY, Lee WS, Yoo JS, Sun JM, Lee J, Park SH, Park JO, Ahn MJ, Lim HY, Kang WK, Park YS. Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors. Investigational New Drugs. PMID 28391576 DOI: 10.1007/s10637-017-0463-y  0.92
2017 Kim ST, Lee J, Park SH, Park JO, Park YS, Kang WK, Lim HY. Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy. Bmc Cancer. 17: 211. PMID 28330462 DOI: 10.1186/s12885-017-3196-6  0.92
2017 Kim SY, Ahn T, Bang H, Ham JS, Kim J, Kim ST, Jang J, Shim M, Kang SY, Park SH, Min BH, Lee H, Kang WK, Kim KM, Park W, et al. Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion. Oncotarget. PMID 28122360 DOI: 10.18632/oncotarget.14788  1
2017 Hwang IG, Ji JH, Kang JH, Lee HR, Lee HY, Chi KC, Park SW, Lee SJ, Kim ST, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK. A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer. Journal of Geriatric Oncology. PMID 28119041 DOI: 10.1016/j.jgo.2017.01.002  0.92
2017 Cho J, Lee J, Bang H, Kim ST, Park SH, An JY, Choi MG, Lee JH, Sohn TS, Bae JM, Kang WK, Kim S, Kim KM. Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability. Oncotarget. PMID 28076847 DOI: 10.18632/oncotarget.14519  0.92
2016 Kim JH, Lee SH, Choi S, Kim U, Yeo IS, Kim SH, Oh MJ, Moon H, Lee J, Jeong S, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, ... ... Kang WK, et al. Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer. Oncotarget. PMID 28052004 DOI: 10.18632/oncotarget.14362  0.92
2016 Lee H, Lee J, Sohn I, Park SH, Park JO, Park YS, Kim KM, Kang WK, Kim ST. To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients. Journal of Cancer. 7: 2173-2178. PMID 27994652 DOI: 10.7150/jca.16551  0.92
2016 Lim SH, Kim SY, Kim K, Jang H, Ahn S, Kim KM, Kim NK, Park W, Lee SJ, Kim ST, Park SH, Park JO, Park YS, Lee SH, Lim HY, ... ... Kang WK, et al. The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors. Oncotarget. PMID 27906677 DOI: 10.18632/oncotarget.13700  0.92
2016 Das K, Chan XB, Epstein D, Teh BT, Kim KM, Kim ST, Park SH, Kang WK, Rozen S, Lee J, Tan P. NanoString expression profiling identifies candidate biomarkers of RAD001 response in metastatic gastric cancer. Esmo Open. 1: e000009. PMID 27843583 DOI: 10.1136/esmoopen-2015-000009  0.92
2016 Kim Y, Park SH, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Lee SJ, Kim ST, Lee J, Park JO, Park YS, Lim HY, Kang WK. The Influence of Metastatic Lymph Node Ratio on the Treatment Outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Trial: A Phase III Trial. Journal of Gastric Cancer. 16: 105-10. PMID 27433396 DOI: 10.5230/jgc.2016.16.2.105  0.92
2016 Kim ST, Lee SJ, Park SH, Park JO, Lim HY, Kang WK, Lee J, Park YS. Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era. Journal of Cancer. 7: 1044-8. PMID 27326246 DOI: 10.7150/jca.14815  0.92
2016 Kang W, Hyun DW, Kim PS, Shin NR, Kim HS, Lee JY, Tak EJ, Roh JR, Park SD, Shim HE, Bae JW. Flexivirga lutea sp. nov., isolated from the feces of a crested ibis, Nipponia nippon, and emended description of genus Flexivirga. International Journal of Systematic and Evolutionary Microbiology. PMID 27295948 DOI: 10.1099/ijsem.0.001238  0.76
2016 Kim HJ, Kang WY, Seong SJ, Kim SY, Lim MS, Yoon YR. Follistatin-like 1 promotes osteoclast formation via RANKL-mediated NF-κB activation and M-CSF-induced precursor proliferation. Cellular Signalling. PMID 27234130 DOI: 10.1016/j.cellsig.2016.05.018  0.68
2016 Ahn S, Lee J, Hong M, Kim ST, Park SH, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Jung SH, Kang WK, Kim KM. FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27230412 DOI: 10.1038/modpathol.2016.96  0.8
2016 Kim HS, Hyun DW, Lee JY, Kim PS, Whon TW, Kang W, Bae JW. Sedimentitalea todarodis sp. nov., isolated from the intestinal tract of a Japanese flying squid. International Journal of Systematic and Evolutionary Microbiology. PMID 27226032 DOI: 10.1099/ijsem.0.001188  0.76
2016 Lee JY, Lee I, Chang WJ, Ahn SM, Lim SH, Kim HS, Yoo KH, Jung KS, Song HN, Cho JH, Kim SY, Kim KM, Lee S, Kim ST, Park SH, ... ... Kang WK, et al. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis. Oncotarget. PMID 27224918 DOI: 10.18632/oncotarget.9523  0.88
2016 Seong SJ, Lim MS, Lee J, Ohk B, Gwon MR, Kim BK, Kim HJ, Yang DH, Lee HW, Kang WY, Yoon YR. Evaluation of a Pharmacokinetic Interaction between Telmisartan and Chlorthalidone in Healthy Male Adult Subjects. Clinical Drug Investigation. PMID 27206575 DOI: 10.1007/s40261-016-0406-y  0.68
2016 Ahn S, Hong M, Van Vrancken M, Lyou YJ, Kim ST, Park SH, Kang WK, Park YS, Jung SH, Woo M, Lee J, Kim KM. A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer. Molecular Diagnosis & Therapy. PMID 27179810 DOI: 10.1007/s40291-016-0205-4  0.8
2016 Yu JI, Park HC, Choi DH, Noh JM, Oh D, Park JS, Chang JH, Kim ST, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK. Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer. Radiation Oncology Journal. 34: 34-44. PMID 27104165 DOI: 10.3857/roj.2016.34.1.34  0.8
2016 Kim ST, Lee J, Lee SJ, Park SH, Jung SH, Park YS, Lim HY, Kang WK, Park JO. Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer. Oncotarget. PMID 27003363 DOI: 10.18632/oncotarget.8175  0.8
2016 Kim ST, Ahn S, Lee J, Lee SJ, Park SH, Park YS, Lim HY, Kang WK, Kim KM, Park JO. Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin). Journal of Cancer Research and Clinical Oncology. PMID 26983912 DOI: 10.1007/s00432-016-2143-2  0.8
2016 Kim HJ, Ohk B, Kang WY, Seong SJ, Suk K, Lim MS, Kim SY, Yoon YR. Deficiency of Lipocalin-2 Promotes Proliferation and Differentiation of Osteoclast Precursors via Regulation of c-Fms Expression and Nuclear Factor-kappa B Activation. Journal of Bone Metabolism. 23: 8-15. PMID 26981515 DOI: 10.11005/jbm.2016.23.1.8  0.8
2016 Kim ST, Ha SY, Lee S, Ahn S, Lee J, Park SH, Park JO, Lim HY, Kang WK, Kim KM, Park YS. The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs. Journal of Cancer. 7: 484-9. PMID 26958083 DOI: 10.7150/jca.13711  1
2016 Song HN, Lee C, Kim ST, Kim SY, Kim NK, Jang J, Kang M, Jang H, Ahn S, Kim SH, Park Y, Cho YB, Heo JW, Lee WY, Park JO, ... ... Kang WK, et al. Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment. Oncotarget. PMID 26909603 DOI: 10.18632/oncotarget.7526  0.8
2016 Kwon DH, Eom GH, Ko JH, Shin S, Joung H, Choe N, Nam YS, Min HK, Kook T, Yoon S, Kang W, Kim YS, Kim HS, Choi H, Koh JT, et al. MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification. Nature Communications. 7: 10492. PMID 26832969 DOI: 10.1038/ncomms10492  0.4
2016 Kye BH, Lee YS, Cho HM, Kim JG, Oh ST, Lee IK, Kang WK, Ahn CH, Lee SC, Park JK, Kim HJ. Comparison of Long-Term Outcomes Between Emergency Surgery and Bridge to Surgery for Malignant Obstruction in Right-Sided Colon Cancer: A Multicenter Retrospective Study. Annals of Surgical Oncology. PMID 26812909 DOI: 10.1245/s10434-015-5053-7  0.48
2016 Kim HS, Kang WK, Chung DJ. Appendiceal Immunoglobulin G4-Related Disease Mimicking Appendiceal Tumor or Appendicitis: A Case Report. Korean Journal of Radiology. 17: 56-8. PMID 26798216 DOI: 10.3348/kjr.2016.17.1.56  0.48
2016 Kim HS, Kim PS, Hyun DW, Lee JY, Kang W, Shin NR, Whon TW, Bae JW. Pseudahrensia todarodis sp. nov., isolated from the gut of a Japanese flying squid, Todarodes pacificus. International Journal of Systematic and Evolutionary Microbiology. PMID 26763785 DOI: 10.1099/ijsem.0.000888  0.76
2015 Jung KS, Park JY, Chon YE, Kim HS, Kang W, Kim BK, Kim SU, Kim DY, Han KH, Ahn SH. Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients. Journal of Gastroenterology. PMID 26687058 DOI: 10.1007/s00535-015-1153-1  0.44
2015 Kang W, Kim PS, Hyun DW, Lee JY, Kim HS, Oh SJ, Shin NR, Bae JW. Comamonas piscis sp. nov., isolated from the intestine of a Korean rockfish, Sebastes schlegelii. International Journal of Systematic and Evolutionary Microbiology. PMID 26612039 DOI: 10.1099/ijsem.0.000790  0.76
2015 Kim MK, Won DY, Lee JK, Kang WK, Kye BH, Cho HM, Kim HJ, Kim JG. Laparoscopic Surgery for Transverse Colon Cancer: Short- and Long-Term Outcomes in Comparison with Conventional Open Surgery. Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A. PMID 26583447 DOI: 10.1089/lap.2015.0122  0.56
2015 Oh DY, Lee KW, Cho JY, Kang WK, Im SA, Kim JW, Bang YJ. Phase II trial of dacomitinib in patients with HER2-positive gastric cancer. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 26581547 DOI: 10.1007/s10120-015-0567-z  0.88
2015 Kang WJ. F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques. Korean Journal of Radiology. 16: 1257-61. PMID 26576114 DOI: 10.3348/kjr.2015.16.6.1257  0.48
2015 Kim HJ, Cho A, Yun M, Kim YT, Kang WJ. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Annals of Nuclear Medicine. PMID 26546334 DOI: 10.1007/s12149-015-1037-8  0.48
2015 Lim SH, Kim TW, Hong YS, Han SW, Lee KH, Kang HJ, Hwang IG, Lee JY, Kim HS, Kim ST, Lee J, Park JO, Park SH, Park YS, Lim HY, ... ... Kang WK, et al. A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer. British Journal of Cancer. PMID 26505681 DOI: 10.1038/bjc.2015.371  0.36
2015 Kim ST, Lira M, Deng S, Lee S, Park YS, Lim HY, Kang WK, Mao M, Heo JS, Kwon W, Jang KT, Lee J, Park JO. PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA. Oncotarget. PMID 26498688 DOI: 10.18632/oncotarget.5432  1
2015 Kim ST, Ahn TJ, Lee E, Do IG, Lee SJ, Park SH, Park JO, Park YS, Lim HY, Kang WK, Kim SH, Lee J, Kim HC. Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan. Bmc Cancer. 15: 747. PMID 26486455 DOI: 10.1186/s12885-015-1759-y  0.88
2015 Lee SJ, Li GG, Kim ST, Hong ME, Jang J, Yoon N, Ahn SM, Murphy D, Christiansen J, Wei G, Hornby Z, Lee DW, Park JO, Park YS, Lim HY, ... ... Kang WK, et al. NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line. Oncotarget. PMID 26472021 DOI: 10.18632/oncotarget.5494  0.8
2015 Kim ST, Lee WS, Lanman RB, Mortimer S, Zill OA, Kim KM, Jang KT, Kim SH, Park SH, Park JO, Park YS, Lim HY, Eltoukhy H, Kang WK, Lee WY, et al. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients. Oncotarget. PMID 26452027 DOI: 10.18632/oncotarget.5465  0.88
2015 Kim TG, Park W, Choi DH, Park HC, Kim SH, Cho YB, Yun SH, Kim HC, Lee WY, Lee J, Park JO, Park YS, Lim HY, Kang WK, Chun HK. Clinical significance of mucinous rectal adenocarcinoma following preoperative chemoradiotherapy and curative surgery. Tumori. 0. PMID 26450451 DOI: 10.5301/tj.5000439  0.48
2015 Hyun DW, Oh SJ, Kim MS, Whon TW, Jung MJ, Shin NR, Kim PS, Kim HS, Lee JY, Kang W, Bae JW. Simplicispira piscis sp. nov., isolated from the gut of a Korean rockfish, Sebastes schlegelii. International Journal of Systematic and Evolutionary Microbiology. PMID 26400548 DOI: 10.1099/ijsem.0.000635  0.76
2015 Kim ST, Lee J, Hong M, Park K, Park JO, Ahn TJ, Park SH, Park YS, Lim HY, Sun JM, Ahn JS, Ahn MJ, Kim HC, Sohn TS, Choi DI, ... ... Kang WK, et al. The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis. Oncotarget. PMID 26396172  0.92
2015 Kang W, Yun YR, Lee DS, Kim TH, Kim JH, Kim HW, Jang JH. Fluorescence-based retention assays reveals sustained release of vascular endothelial growth factor from bone grafts. Journal of Biomedical Materials Research. Part A. PMID 26386269 DOI: 10.1002/jbm.a.35566  0.6
2015 Lee J, Ou SI, Lee JM, Kim HC, Hong M, Kim SY, Jang J, Ahn S, Kang SY, Lee S, Kim ST, Kim B, Choi J, Kim KA, Lee J, ... ... Kang WK, et al. Gastrointestinal malignancies harbor actionable MET exon 14 deletions. Oncotarget. PMID 26375439  1
2015 Yi JH, Kang JH, Hwang IG, Ahn HK, Baek HJ, Lee SI, Lim DH, Won YW, Ji JH, Kim HS, Rha SY, Oh SY, Lee KE, Lim T, Maeng CH, ... ... Kang WK, et al. A Retrospective Analysis for Patients with HER2 Positive Gastric Cancer who were Treated with Trastuzumab-based Chemotherapy: In the Perspectives of Ethnicity and Histology. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 26323641 DOI: 10.4143/crt.2015.155  0.8
2015 Kim ST, Jang HL, Lee J, Park SH, Park YS, Lim HY, Choi MG, Bae JM, Sohn TS, Noh JH, Kim S, Kim KM, Kang WK, Park JO. Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer. Translational Oncology. 8: 288-294. PMID 26310375 DOI: 10.1016/j.tranon.2015.06.001  0.92
2015 Yu JI, Lim DH, Ahn YC, Lee J, Kang WK, Park SH, Park JO, Park YS, Lim HY, Kim ST, Kim S, Sohn TS, Choi MG, Bae JM, Nam H. Effects of adjuvant radiotherapy on completely resected gastric cancer: A radiation oncologist's view of the ARTIST randomized phase III trial. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26299196 DOI: 10.1016/j.radonc.2015.08.009  0.88
2015 Lee JY, Kim SY, Park C, Kim NK, Jang J, Park K, Yi JH, Hong M, Ahn T, Rath O, Schueler J, Kim ST, Do IG, Lee S, Park SH, ... ... Kang WK, et al. Patient-derived cell models as preclinical tools for genome-directed targeted therapy. Oncotarget. PMID 26296973 DOI: 10.18632/oncotarget.4627  1
2015 Kim HJ, Yoon HJ, Kim BK, Kang WY, Seong SJ, Lim MS, Kim SY, Yoon YR. G Protein-Coupled Receptor 120 Signaling Negatively Regulates Osteoclast Differentiation, Survival, and Function. Journal of Cellular Physiology. PMID 26280807 DOI: 10.1002/jcp.25133  0.68
2015 Lim T, Lee I, Kim J, Kang WK. Synergistic Effect of Simvastatin Plus Radiation in Gastric Cancer and Colorectal Cancer: Implications of BIRC5 and Connective Tissue Growth Factor. International Journal of Radiation Oncology, Biology, Physics. 93: 316-25. PMID 26277021 DOI: 10.1016/j.ijrobp.2015.05.023  1
2015 Kim ST, Jang KT, Lee SJ, Jang HL, Lee J, Park SH, Park YS, Lim HY, Kang WK, Park JO. Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer. Bmc Cancer. 15: 530. PMID 26189560 DOI: 10.1186/s12885-015-1552-y  0.88
2015 Lee J, Kim HC, Hong JY, Wang K, Kim SY, Jang J, Kim ST, Park JO, Lim HY, Kang WK, Park YS, Lee J, Lee WY, Park YA, Huh JW, et al. Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening. Oncotarget. PMID 26172300 DOI: 10.18632/oncotarget.4462  0.88
2015 Kim BK, Shin DH, Hong MK, Park HS, Rha SW, Mintz GS, Kim JS, Kim JS, Lee SJ, Kim HY, Hong BK, Kang WC, Choi JH, Jang Y. Clinical Impact of Intravascular Ultrasound-Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation: Randomized Study. Circulation. Cardiovascular Interventions. 8. PMID 26156151 DOI: 10.1161/CIRCINTERVENTIONS.115.002592  0.88
2015 Park SH, Breitbach CJ, Lee J, Park JO, Lim HY, Kang WK, Moon A, Mun JH, Sommermann EM, Maruri Avidal L, Patt R, Pelusio A, Burke J, Hwang TH, Kirn D, et al. Phase Ib trial of biweekly intravenous Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus in colorectal cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26073886 DOI: 10.1038/mt.2015.109  0.48
2015 Lee SJ, Lee J, Kim ST, Park SH, Park JO, Park YS, Lim HY, Kang WK. Circulating tumor cells are predictive of poor response to chemotherapy in metastatic gastric cancer. The International Journal of Biological Markers. 0. PMID 26044775 DOI: 10.5301/jbm.5000151  0.92
2015 Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, Ye XS, Do IG, Liu S, Gong L, Fu J, ... ... Kang WK, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nature Medicine. 21: 449-56. PMID 25894828 DOI: 10.1038/nm.3850  0.88
2015 Lee JY, Hong M, Kim ST, Park SH, Kang WK, Kim KM, Lee J. The impact of concomitant genomic alterations on treatment outcome for trastuzumab therapy in HER2-positive gastric cancer. Scientific Reports. 5: 9289. PMID 25786580 DOI: 10.1038/srep09289  0.92
2015 Kim M, Lee S, Lee J, Park SH, Park JO, Park YS, Kang WK, Kim ST. The Role of Plasma Chromogranin A as Assessment of Treatment Response in Non-Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 25779359 DOI: 10.4143/crt.2014.183  0.8
2015 Kim ST, Jang KT, Lee J, Jang HM, Choi HJ, Jang HL, Park SH, Park YS, Lim HY, Kang WK, Park JO. Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer. Translational Oncology. 8: 40-6. PMID 25749176 DOI: 10.1016/j.tranon.2014.12.003  0.92
2015 Choi JY, Kang W, Kang B, Cha W, Son SK, Yoon Y, Kim H, Kang Y, Ko MJ, Son HJ, Cho K, Cho JH, Kim B. High performance of low band gap polymer-based ambipolar transistor using single-layer graphene electrodes. Acs Applied Materials & Interfaces. 7: 6002-12. PMID 25734886 DOI: 10.1021/acsami.5b00747  0.4
2015 Jhee JH, Kim HJ, Kang W, Kim S, Kim do Y. A case of autoimmune hepatitis combined with Graves' disease. The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi. 65: 48-51. PMID 25603854  0.8
2015 Park SH, Sohn TS, Lee J, Lim DH, Hong ME, Kim KM, Sohn I, Jung SH, Choi MG, Lee JH, Bae JM, Kim S, Kim ST, Park JO, Park YS, ... ... Kang WK, et al. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 25559811 DOI: 10.1200/JCO.2014.58.3930  0.88
2015 Lee JH, Shim W, Choolakadavil Khalid N, Kang WS, Lee M, Kim HS, Choi J, Lee G, Kim JH. Random networks of single-walled carbon nanotubes promote mesenchymal stem cell's proliferation and differentiation. Acs Applied Materials & Interfaces. 7: 1560-7. PMID 25546303 DOI: 10.1021/am506833q  0.44
2015 Kang TW, Kim SH, Jang KM, Choi D, Ha SY, Kim KM, Kang WK, Kim MJ. Gastrointestinal stromal tumours: correlation of modified NIH risk stratification with diffusion-weighted MR imaging as an imaging biomarker. European Journal of Radiology. 84: 33-40. PMID 25466773 DOI: 10.1016/j.ejrad.2014.10.020  0.88
2015 Lee J, Hong YS, Hong JY, Han SW, Kim TW, Kang HJ, Kim TY, Kim KP, Kim SH, Do IG, Kim KM, Sohn I, Park SH, Park JO, Lim HY, ... ... Kang WK, et al. Erratum to: Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab. Investigational New Drugs. 33: 269-70. PMID 25236593 DOI: 10.1007/s10637-014-0162-x  0.92
2015 Ha SY, Lee J, Jang J, Hong JY, Do IG, Park SH, Park JO, Choi MG, Sohn TS, Bae JM, Kim S, Kim M, Kim S, Park CK, Kang WK, et al. HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy. International Journal of Cancer. Journal International Du Cancer. 136: 1629-35. PMID 25157953 DOI: 10.1002/ijc.29159  0.92
2015 Jung HA, Kim HJ, Maeng CH, Park SH, Lee J, Park JO, Park YS, Lim HY, Kang WK. Changes in the mean corpuscular volume after capecitabine treatment are associated with clinical response and survival in patients with advanced gastric cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 47: 72-7. PMID 25143051 DOI: 10.4143/crt.2013.172  0.92
2015 Kim ST, Lee J, Hong M, Park K, Park JO, Ahn TJ, Park SH, Park YS, Lim HY, Sun JM, Ahn JS, Ahn MJ, Kim HC, Sohn TS, Choi DI, ... ... Kang WK, et al. The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: Prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis Oncotarget. 6: 33358-33368. DOI: 10.18632/oncotarget.5188  0.88
2014 Yi JH, Do IG, Jang J, Kim ST, Kim KM, Park SH, Park JO, Park YS, Lim HY, Kang WK, Lee J. Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer. Scientific Reports. 4: 7592. PMID 25534230 DOI: 10.1038/srep07592  0.92
2014 Kim S, Lee J, Hong ME, Do IG, Kang SY, Ha SY, Kim ST, Park SH, Kang WK, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Kim DH, et al. High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer. Plos One. 9: e111693. PMID 25372287 DOI: 10.1371/journal.pone.0111693  0.92
2014 Lee YK, Park EY, Kim S, Son JY, Kim TH, Kang WG, Jeong TC, Kim KB, Kwack SJ, Lee J, Kim S, Lee BM, Kim HS. Evaluation of cadmium-induced nephrotoxicity using urinary metabolomic profiles in sprague-dawley male rats. Journal of Toxicology and Environmental Health. Part A. 77: 1384-98. PMID 25343288 DOI: 10.1080/15287394.2014.951755  0.36
2014 Kim GH, Kang MJ, Noh K, Oh do G, Kang W, Jeong HG, Lee KY, Kim H, Kim HS, Jeong TC. Nephrotoxic potential and toxicokinetics of melamine combined with cyanuric acid in rats. Journal of Toxicology and Environmental Health. Part A. 77: 1346-58. PMID 25343285 DOI: 10.1080/15287394.2014.951592  0.8
2014 Kim ST, Jang HL, Lee SJ, Lee J, Choi YL, Kim KM, Cho J, Park SH, Park YS, Lim HY, Yashiro M, Kang WK, Park JO. Pazopanib, a novel multitargeted kinase inhibitor, shows potent in vitro antitumor activity in gastric cancer cell lines with FGFR2 amplification. Molecular Cancer Therapeutics. 13: 2527-36. PMID 25249557 DOI: 10.1158/1535-7163.MCT-14-0255  0.92
2014 Kim ST, Kang JH, Lee J, Park SH, Park JO, Park YS, Lim HY, Hwang IG, Lee SC, Park KW, Lee HR, Kang WK. Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: a double-blind randomised phase 3 study. European Journal of Cancer (Oxford, England : 1990). 50: 2822-30. PMID 25218337 DOI: 10.1016/j.ejca.2014.08.005  0.92
2014 Hwang ET, Kang WS, Park JW, Lee JH, Han HJ, Shin SY, Kim HJ, Choi JS. [Portal-splenic-mesenteric venous thrombosis in a patients with protein S deficiency due to novel PROS1 gene mutation]. The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi. 64: 110-4. PMID 25168054  0.8
2014 Park JS, Park HC, Choi DH, Park W, Yu JI, Park YS, Kang WK, Park JO. Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases. Radiation Oncology Journal. 32: 77-83. PMID 25061576 DOI: 10.3857/roj.2014.32.2.77  0.92
2014 Lee J, Sohn I, Do IG, Kim KM, Park SH, Park JO, Park YS, Lim HY, Sohn TS, Bae JM, Choi MG, Lim do H, Min BH, Lee JH, Rhee PL, ... ... Kang WK, et al. Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery. Plos One. 9: e90133. PMID 24598828 DOI: 10.1371/journal.pone.0090133  0.88
2014 Lee J, Hong YS, Hong JY, Han SW, Kim TW, Kang HJ, Kim TY, Kim KP, Kim SH, Do IG, Kim KM, Sohn I, Park SH, Park JO, Lim HY, ... ... Kang WK, et al. Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab. Investigational New Drugs. 32: 535-41. PMID 24468885 DOI: 10.1007/s10637-014-0065-x  0.88
2014 Kim TG, Park W, Choi DH, Park HC, Kim SH, Cho YB, Yun SH, Kim HC, Lee WY, Lee J, Park JO, Park YS, Lim HY, Kang WK, Chun HK. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients. International Journal of Colorectal Disease. 29: 193-200. PMID 24322736 DOI: 10.1007/s00384-013-1797-3  0.92
2014 Ha SY, Do IG, Lee J, Park SH, Park JO, Kang WK, Choi MG, Lee JH, Bae JM, Kim S, Kim KM, Sohn TS. CD151 overexpression is associated with poor prognosis in patients with pT3 gastric cancer. Annals of Surgical Oncology. 21: 1099-106. PMID 24306658 DOI: 10.1245/s10434-013-3339-1  0.92
2014 Hong JY, Nam EM, Lee J, Park JO, Lee SC, Song SY, Choi SH, Heo JS, Park SH, Lim HY, Kang WK, Park YS. Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients. Cancer Chemotherapy and Pharmacology. 73: 125-30. PMID 24162380 DOI: 10.1007/s00280-013-2328-1  0.92
2014 Kang W, Kang C. Large deviations for affine diffusion processes on ℝ+ m × ℝn Stochastic Processes and Their Applications. 124: 2188-2227. DOI: 10.1016/j.spa.2014.02.002  0.96
2013 Baba E, Lee KH, Boku N, Park YI, Hyodo I, Nam BH, Esaki T, Ryoo BY, Song EK, Cho S, Lee SS, Kang WK, Yang SH, Zang DY, Shin DB, et al. Phase III trial of a 3-weekly versus 5-weekly schedule of S-1 plus cisplatin (SP) combination chemotherapy for first-line treatment of advanced gastric cancer (AGC): SOS study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: LBA4024. PMID 28136048 DOI: 10.1200/jco.2013.31.18_suppl.lba4024  0.84
2013 Kang G, Hwang WC, Do IG, Wang K, Kang SY, Lee J, Park SH, Park JO, Kang WK, Jang J, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, et al. Exome sequencing identifies early gastric carcinoma as an early stage of advanced gastric cancer. Plos One. 8: e82770. PMID 24376576 DOI: 10.1371/journal.pone.0082770  0.92
2013 Kang W, Kim SU. Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD. Clinical and Molecular Hepatology. 19: 255-7. PMID 24133662 DOI: 10.3350/cmh.2013.19.3.255  0.56
2013 Lee SJ, Lee J, Lee J, Park SH, Park JO, Park YS, Lim HY, Kim KM, Do IG, Jung SH, Yim DS, Kang WK. Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients. Investigational New Drugs. 31: 1580-6. PMID 24013904 DOI: 10.1007/s10637-013-0022-0  0.88
2013 Qin S, Bai Y, Lim HY, Thongprasert S, Chao Y, Fan J, Yang TS, Bhudhisawasdi V, Kang WK, Zhou Y, Lee JH, Sun Y. Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3501-8. PMID 23980077 DOI: 10.1200/JCO.2012.44.5643  0.88
2013 Ha SY, Lee J, Kang SY, Do IG, Ahn S, Park JO, Kang WK, Choi MG, Sohn TS, Bae JM, Kim S, Kim M, Kim S, Park CK, Ignatius Ou SH, et al. MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 1632-41. PMID 23807774 DOI: 10.1038/modpathol.2013.108  0.92
2013 Lee J, Lee SE, Kang SY, Do IG, Lee S, Ha SY, Cho J, Kang WK, Jang J, Ou SH, Kim KM. Identification of ROS1 rearrangement in gastric adenocarcinoma. Cancer. 119: 1627-35. PMID 23400546 DOI: 10.1002/cncr.27967  1
2013 Lee J, Kim S, Kim P, Liu X, Lee T, Kim KM, Do IG, Park JO, Park SH, Jang J, Hoe N, Harvie G, Kuller A, Jain A, Meyer G, ... ... Kang WK, et al. A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers. Plos One. 8: e54644. PMID 23372746 DOI: 10.1371/journal.pone.0054644  0.88
2013 Lee KH, Chang HJ, Han SW, Oh DY, Im SA, Bang YJ, Kim SY, Lee KW, Kim JH, Hong YS, Kim TW, Park YS, Kang WK, Shin SJ, Ahn JB, et al. Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer. Cancer Chemotherapy and Pharmacology. 71: 843-51. PMID 23314736 DOI: 10.1007/s00280-013-2075-3  0.88
2013 Lee I, Lee SJ, Kang TM, Kang WK, Park C. Unconventional role of the inwardly rectifying potassium channel Kir2.2 as a constitutive activator of RelA in cancer. Cancer Research. 73: 1056-62. PMID 23269273 DOI: 10.1158/0008-5472.CAN-12-2498  0.88
2013 Cho EY, Park K, Do I, Cho J, Kim J, Lee J, Kim S, Kim KM, Sohn TS, Kang WK, Kim S. Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 677-84. PMID 23238628 DOI: 10.1038/modpathol.2012.205  1
2013 Kang C, Kang W. Transform formulae for linear functionals of affine processes and their bridges on positive semidefinite matrices Stochastic Processes and Their Applications. 123: 2419-2445. DOI: 10.1016/j.spa.2013.02.011  0.96
2013 Kang WJ. Myocardial viability Clinical Pet and Pet/Ct: Principles and Applications. 241-247. DOI: 10.1007/978-1-4419-0802-5_20  0.48
2012 Lee J, Lee SH, Hur KY, Woo SY, Kim SW, Kang WK. Statins and the risk of gastric cancer in diabetes patients Bmc Cancer. 12. PMID 23234464 DOI: 10.1186/1471-2407-12-596  0.88
2012 Lee SJ, Park LC, Lee J, Kim S, Choi MK, Hong JY, Park S, Maeng CH, Chang W, Kim YS, Park SH, Park JO, Lim HY, Kang WK, Park YS. Unique perception of clinical trials by Korean cancer patients. Bmc Cancer. 12: 594. PMID 23234342 DOI: 10.1186/1471-2407-12-594  0.92
2012 Kang YK, Kang BW, Im SA, Lee JL, Park SR, Kang WK, Chang HM, Kim TW, Oh DY, Jung KH, Ryu MH. Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation. Cancer Chemotherapy and Pharmacology. 71: 43-51. PMID 23053257 DOI: 10.1007/s00280-012-1970-3  0.32
2012 Kang G, Lee J, Jang KT, Beadling C, Corless CL, Heinrich MC, Park JO, Kang WK, Park CK, Kim KM. Multiplex mutation screening by mass spectrometry in gastrointestinal stromal tumours. Pathology. 44: 460-4. PMID 22777070 DOI: 10.1097/PAT.0b013e3283559c45  0.88
2012 Lee J, van Hummelen P, Go C, Palescandolo E, Jang J, Park HY, Kang SY, Park JO, Kang WK, MacConaill L, Kim KM. High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma. Plos One. 7: e38892. PMID 22723903 DOI: 10.1371/journal.pone.0038892  0.88
2012 Yi JH, Lee J, Lee J, Park SH, Park JO, Yim DS, Park YS, Lim HY, Kang WK. Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum. British Journal of Cancer. 106: 1469-74. PMID 22460270 DOI: 10.1038/bjc.2012.100  0.92
2012 Cho EY, Srivastava A, Park K, Kim J, Lee MH, Do I, Lee J, Kim KM, Sohn TS, Kang WK, Kim S. Comparison of four immunohistochemical tests and FISH for measuring HER2 expression in gastric carcinomas. Pathology. 44: 216-20. PMID 22437741 DOI: 10.1097/PAT.0b013e3283513e8b  1
2012 Lee DJ, Sohn TS, Lim do H, Ahn HK, Park SH, Lee J, Park JO, Park YS, Lim HY, Choi DI, Kim KM, Choi MG, Noh JH, Bae JM, Kim S, ... ... Kang WK, et al. Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 69: 1333-8. PMID 22311161 DOI: 10.1007/s00280-012-1836-8  0.92
2012 Lee J, Lim do H, Kim S, Park SH, Park JO, Park YS, Lim HY, Choi MG, Sohn TS, Noh JH, Bae JM, Ahn YC, Sohn I, Jung SH, Park CK, ... ... Kang WK, et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 268-73. PMID 22184384 DOI: 10.1200/JCO.2011.39.1953  0.88
2012 Yi JH, Thongprasert S, Lee J, Doval DC, Park SH, Park JO, Park YS, Kang WK, Lim HY. A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: a multicentre, multinational study. European Journal of Cancer (Oxford, England : 1990). 48: 196-201. PMID 22176869 DOI: 10.1016/j.ejca.2011.11.017  0.92
2012 Ahn HK, Lee S, Sun JM, Lee J, Park SH, Park JO, Park YS, Kang WK, Lim HY. Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma. Investigational New Drugs. 30: 1768-72. PMID 21720741 DOI: 10.1007/s10637-011-9707-4  0.88
2012 Lee SJ, Lee J, Park SH, Park JO, Park YS, Kang WK, Lee J, Yim DS, Lim HY. Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma. Investigational New Drugs. 30: 1540-7. PMID 21695438 DOI: 10.1007/s10637-011-9706-5  0.88
2012 Kim ST, Lee J, Park SH, Lee JK, Lee KT, Lee KH, Heo JS, Choi SH, Choi DW, Park YS, Lim HY, Kang WK, Jang KT, Park HC, Lim do H, et al. Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarcinoma: a retrospective review. American Journal of Clinical Oncology. 35: 432-8. PMID 21606820 DOI: 10.1097/COC.0b013e31821a83d7  0.88
2011 Ahn HK, Jang J, Lee J, Se Hoon P, Park JO, Park YS, Lim HY, Kim KM, Kang WK. P21-activated kinase 4 overexpression in metastatic gastric cancer patients. Translational Oncology. 4: 345-9. PMID 22190998 DOI: 10.1593/tlo.11145  0.92
2011 Park S, Lee S, Lee J, Park SH, Park JO, Kang WK, Park YS, Lim HY. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors Onkologie. 34: 416-420. PMID 21934340 DOI: 10.1159/000331129  0.88
2011 Kim ST, Lim do H, Jang KT, Lim T, Lee J, Choi YL, Jang HL, Yi JH, Baek KK, Park SH, Park YS, Lim HY, Kang WK, Park JO. Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy. Molecular Cancer Therapeutics. 10: 1993-9. PMID 21862683 DOI: 10.1158/1535-7163.MCT-11-0269  0.92
2011 Yi JH, Lee J, Park SH, Lee KT, Lee JK, Lee KH, Choi DW, Choi SH, Heo JS, Lim do H, Park YS, Lim HY, Kang WK, Park K, Park JO. A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic cancer. Oncology. 80: 175-80. PMID 21701231 DOI: 10.1159/000328449  0.88
2011 Bae SH, Park W, Choi DH, Nam H, Kang WK, Park YS, Park JO, Chun HK, Lee WY, Yun SH, Kim HC. Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer. Radiation Oncology (London, England). 6: 52. PMID 21600018 DOI: 10.1186/1748-717X-6-52  0.92
2011 Lim T, Lee J, Lee DJ, Lee HY, Han B, Baek KK, Ahn HK, Lee SJ, Park SH, Park JO, Park YS, Lim HY, Kim KM, Kang WK. Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer. Cancer Chemotherapy and Pharmacology. 68: 255-62. PMID 21526353 DOI: 10.1007/s00280-011-1653-5  0.92
2011 Lee J, Seo JW, Jun HJ, Ki CS, Park SH, Park YS, Lim HY, Choi MG, Bae JM, Sohn TS, Noh JH, Kim S, Jang HL, Kim JY, Kim KM, ... Kang WK, et al. Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Oncology Reports. 25: 1517-24. PMID 21424128 DOI: 10.3892/or.2011.1219  0.88
2011 Yoon WS, Park W, Choi DH, Ahn YC, Chun HK, Lee WY, Yun SH, Kim HC, Cho YB, Kang WK, Park YS, Park JO, Lim HY, Park SH, Lee J. Which patients benefit from preoperative chemoradiotherapy for intermediate staged rectal cancer? Onkologie. 34: 36-41. PMID 21346383 DOI: 10.1159/000323382  0.92
2011 Kang WJ, Cho YL, Chae JR, Lee JD, Choi KJ, Kim S. Molecular beacon-based bioimaging of multiple microRNAs during myogenesis. Biomaterials. 32: 1915-22. PMID 21122913 DOI: 10.1016/j.biomaterials.2010.11.007  0.8
2011 Ha YE, Song JH, Kang WK, Peck KR, Chung DR, Kang CI, Joung MK, Joo EJ, Shon KM. Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 19: 1761-7. PMID 20931237 DOI: 10.1007/s00520-010-1017-4  0.88
2011 Song JU, Suh GY, Chung MP, Kim H, Kwon OJ, Jung CW, Kang WK, Park K, Jeon K. Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 19: 491-5. PMID 20229331 DOI: 10.1007/s00520-010-0841-x  0.88
2011 Choi MK, Ahn BJ, Yim DS, Park YS, Kim S, Sohn TS, Noh JH, Heo JS, Lee J, Park SH, Park JO, Lim HY, Kang WK. Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seeding. Cancer Chemotherapy and Pharmacology. 67: 5-11. PMID 20213078 DOI: 10.1007/s00280-010-1272-6  0.92
2011 Kang WK. Is there any relationship between the chronicity of chronic anal fissure and endothelin-1? Journal of the Korean Society of Coloproctology. 27: 221. DOI: 10.3393/jksc.2011.27.5.221  0.56
2010 Baek KK, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK, Cho YB, Yun SH, Kim HC, Lee WY, Chun HK. Oxaliplatin-induced chronic peripheral neurotoxicity: a prospective analysis in patients with colorectal cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 42: 185-90. PMID 21253319 DOI: 10.4143/crt.2010.42.4.185  0.92
2010 Ahn BJ, Choi MK, Park YS, Lee J, Park SH, Park JO, Lim HY, Kang WK, Ko JW, Yim DS. Population pharmacokinetics of CPT-11 (irinotecan) in gastric cancer patients with peritoneal seeding after its intraperitoneal administration. European Journal of Clinical Pharmacology. 66: 1235-45. PMID 20827550 DOI: 10.1007/s00228-010-0885-3  0.92
2010 Yun J, Kim KM, Kim ST, Kim JH, Kim JA, Kong JH, Lee SH, Won YW, Sun JM, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK. Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapy. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 42: 101-6. PMID 20622964 DOI: 10.4143/crt.2010.42.2.101  0.92
2010 Ko YH, Karnan S, Kim KM, Park CK, Kang ES, Kim YH, Kang WK, Kim SJ, Kim WS, Lee WY, Chun HK, Seto M. Enteropathy-associated T-cell lymphoma--a clinicopathologic and array comparative genomic hybridization study. Human Pathology. 41: 1231-7. PMID 20399483 DOI: 10.1016/j.humpath.2009.11.020  0.84
2010 Lim do H, Kim HS, Park YS, Lee J, Park SH, Lim HY, Ji SH, Park MJ, Yi SY, An JY, Sohn TS, Noh JH, Bae JM, Kim S, Park CK, ... Kang WK, et al. Metastatic lymph node in gastric cancer; is it a real distant metastasis? Bmc Cancer. 10: 25. PMID 20113485 DOI: 10.1186/1471-2407-10-25  0.92
2010 Choi MK, Park YH, Hong JY, Park HC, Ahn YC, Kim K, Shim YM, Kang WK, Park K, Im YH. Clinical implications of esophagorespiratory fistulae in patients with esophageal squamous cell carcinoma (SCCA). Medical Oncology (Northwood, London, England). 27: 1234-8. PMID 19924573 DOI: 10.1007/s12032-009-9364-z  0.88
2010 Choi ER, Ko YH, Kim SJ, Jang JH, Kim K, Kang WK, Jung CW, Kim DH. Gastric recurrence of extramedullary granulocytic sarcoma after allogeneic stem cell transplantation for acute myeloid leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: e54-5. PMID 19917867 DOI: 10.1200/JCO.2009.23.7560  0.88
2010 Kim ST, Lee J, Lee KT, Lee JK, Lee KH, Choi SH, Heo JS, Choi DW, Park SH, Park JO, Lim HY, Park YS, Kang WK. The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater. Medical Oncology (Northwood, London, England). 27: 1149-54. PMID 19898973 DOI: 10.1007/s12032-009-9351-4  0.88
2010 Kim HS, Yi SY, Jun HJ, Lee J, Park SH, Lee JK, Lee KT, Lee KH, Choi DW, Choi SH, Heo JS, Park YS, Lim HY, Kang WK, Park HC, et al. Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer. Anti-Cancer Drugs. 21: 107-12. PMID 19829097 DOI: 10.1097/CAD.0b013e328332a7fc  0.92
2009 Kim HS, Park MJ, Uhm JE, Lee Y, Lee HY, Kang EM, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS. A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer. International Journal of Colorectal Disease. 24: 1311-6. PMID 19609538 DOI: 10.1007/s00384-009-0758-3  0.92
2009 Kim TW, Ryu MH, Lee H, Sym SJ, Lee JL, Chang HM, Park YS, Lee KH, Kang WK, Shin DB, Bang YJ, Lee JS, Kang YK. Kinase mutations and efficacy of imatinib in Korean patients with advanced gastrointestinal stromal tumors. The Oncologist. 14: 540-7. PMID 19411681 DOI: 10.1634/theoncologist.2008-0145  0.44
2009 Ji SH, Lim DH, Yi SY, Kim HS, Jun HJ, Kim KH, Chang MH, Park MJ, Uhm JE, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK. A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer. Bmc Cancer. 9: 110. PMID 19358705 DOI: 10.1186/1471-2407-9-110  0.92
2009 Kim HS, Park YH, Park MJ, Chang MH, Jun HJ, Kim KH, Ahn JS, Kang WK, Park K, Im YH. Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer. Breast Cancer Research and Treatment. 118: 89-97. PMID 19322651 DOI: 10.1007/s10549-009-0377-2  0.88
2009 Ryu MH, Kang WK, Bang YJ, Lee KH, Shin DB, Ryoo BY, Roh JK, Kang JH, Lee H, Kim TW, Chang HM, Park JO, Park YS, Kim TY, Kim MK, et al. A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor. Oncology. 76: 326-32. PMID 19307738 DOI: 10.1159/000209384  0.6
2009 Lee J, Jung KH, Park YS, Ahn JB, Shin SJ, Im SA, Oh DY, Shin DB, Kim TW, Lee N, Byun JH, Hong YS, Park JO, Park SH, Lim HY, ... Kang WK, et al. Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study. Cancer Chemotherapy and Pharmacology. 64: 657-63. PMID 19169686 DOI: 10.1007/s00280-008-0913-5  0.92
2009 Park ES, Do IG, Park CK, Kang WK, Noh JH, Sohn TS, Kim S, Kim MJ, Kim KM. Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 291-8. PMID 19118057 DOI: 10.1158/1078-0432.CCR-08-0848  0.84
2009 Kim KH, Park YS, Chang MH, Kim HS, Jun HJ, Uhm J, Yi SY, Lim DH, Ji SH, Park MJ, Lee J, Park SH, Park JO, Lim HY, Kang WK. A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 64: 347-53. PMID 19066894 DOI: 10.1007/s00280-008-0878-4  0.92
2009 Uhm JE, Park YH, Yi SY, Cho EY, Choi YL, Lee SJ, Park MJ, Lee SH, Jun HJ, Ahn JS, Kang WK, Park K, Im YH. Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy. International Journal of Cancer. Journal International Du Cancer. 124: 1457-62. PMID 19065658 DOI: 10.1002/ijc.24090  0.88
2009 Kang W, Lee S. Horizontal parallax distortion correction method in toed-in camera with wide-angle lens 3dtv-Con 2009 - 3rd 3dtv-Conference: the True Vision - Capture, Transmission and Display of 3d Video, Proceedings. DOI: 10.1109/3DTV.2009.5069617  1
2009 Kang W, Chung WY. Liquid water diffusivity of wood from the capillary pressure-moisture relation Journal of Wood Science. 55: 91-99. DOI: 10.1007/s10086-008-1009-x  0.36
2008 Hong JY, Choi MK, Uhm JE, Park MJ, Lee J, Park SH, Park JO, Kim WS, Kang WK, Lee HM, Choi HY, Lim H. Palliative chemotherapy for non-transitional cell carcinomas of the urothelial tract. Medical Oncology (Northwood, London, England). 26: 186-92. PMID 18988001 DOI: 10.1007/s12032-008-9106-7  0.6
2008 Yi SY, Park YS, Kim HS, Jun HJ, Kim KH, Chang MH, Park MJ, Uhm JE, Lee J, Park SH, Park JO, Lee JK, Lee KT, Lim HY, Kang WK. Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology. 63: 1141-5. PMID 18839175 DOI: 10.1007/s00280-008-0839-y  0.48
2008 Uhm JE, Park JO, Lee J, Park YS, Park SH, Yoo BC, Paik SW, Koh KC, Kang WK, Lim HY. A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 63: 929-35. PMID 18726098 DOI: 10.1007/s00280-008-0817-4  0.52
2008 Han AR, Kim K, Jang JH, Kim WS, Ahn JS, Jung CW, Lee MH, Kang WK. Outcomes of a modified CALGB 19802 regimen in adult acute lymphoblastic leukemia. Journal of Korean Medical Science. 23: 278-83. PMID 18437012 DOI: 10.3346/jkms.2008.23.2.278  0.6
2008 Kim HS, Yi SY, Jun HJ, Lee J, Park JO, Park YS, Jang J, Kim HJ, Ko Y, Lim HY, Kang WK. Clinical outcome of gastric cancer patients with bone marrow metastases. Oncology. 73: 192-7. PMID 18418012 DOI: 10.1159/000127386  0.36
2008 Park BB, Im YH, Hwang IG, Lee SC, Ahn JS, Ahn MJ, Lim HY, Kang WK, Park K. Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma. Investigational New Drugs. 26: 387-92. PMID 18368291 DOI: 10.1007/s10637-008-9126-3  0.92
2008 Nam H, Lim DH, Kim S, Kang WK, Sohn TS, Noh JH, Kim YI, Park CH, Park CK, Ahn YC, Huh SJ. A New Suggestion for the Radiation Target Volume After a Subtotal Gastrectomy in Patients With Stomach Cancer International Journal of Radiation Oncology Biology Physics. 71: 448-455. PMID 18234442 DOI: 10.1016/j.ijrobp.2007.09.055  0.88
2008 Lee J, Park CK, Park JO, Lim T, Park YS, Lim HY, Lee I, Sohn TS, Noh JH, Heo JS, Kim S, Lim DH, Kim KM, Kang WK. Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 82-8. PMID 18172256 DOI: 10.1158/1078-0432.CCR-07-0612  0.44
2008 Lee J, Im YH, Cho EY, Hong YS, Lee HR, Kim HS, Kim MJ, Kim K, Kang WK, Park K, Shim YM. A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma. Cancer Chemotherapy and Pharmacology. 62: 77-84. PMID 17762932 DOI: 10.1007/s00280-007-0577-6  0.92
2008 Lee YJ, Shin JU, Lee J, Kim K, Kim WS, Ahn JS, Jung CW, Kang WK. A case of deep vein thrombosis and pulmonary thromboembolism after intravenous immunoglobulin therapy. Journal of Korean Medical Science. 22: 758-61. PMID 17728525 DOI: 10.3346/jkms.2007.22.4.758  0.64
2008 Kang W. Oscillations of the interlayer resistance in the quasi-two-dimensional organic conductor β-(BEDT-TTF)2I3 under pressure Physica E: Low-Dimensional Systems and Nanostructures. 40: 1671-1673. DOI: 10.1016/j.physe.2007.10.052  0.64
2008 Kang W, Son SH. Data services in distributed real-time embedded systems Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 5287: 162-173. DOI: 10.1007/978-3-540-87785-1_15  0.48
2007 Kim YH, Chung HC, Kang WK, Park SR, Kim CS, Kim TY, Shin SW, Park BJ, Cha SJ, Bang YJ. Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study. Cancer Chemotherapy and Pharmacology. 62: 263-70. PMID 17960386 DOI: 10.1007/s00280-007-0600-y  0.48
2007 Park S, Lee J, Ko YH, Han A, Jun HJ, Lee SC, Hwang IG, Park YH, Ahn JS, Jung CW, Kim K, Ahn YC, Kang WK, Park K, Kim WS. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood. 110: 972-8. PMID 17400912 DOI: 10.1182/blood-2007-01-067769  0.92
2007 Park BB, Park JO, Lee HR, Lee J, Choi DW, Choi SH, Heo JS, Lee JK, Lee KT, Lim do H, Park YS, Lim HY, Kang WK, Park K. A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma. Cancer Chemotherapy and Pharmacology. 60: 489-94. PMID 17396266 DOI: 10.1007/s00280-006-0390-7  0.92
2007 Uhm JE, Kim K, Lim TK, Park BB, Park S, Hong YS, Lee SC, Hwang IG, Koh KC, Lee MH, Ahn JS, Kim WS, Jung CW, Kang WK. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 463-8. PMID 17382252 DOI: 10.1016/j.bbmt.2006.11.019  0.88
2007 Lee J, Jang KT, Ki CS, Lim T, Park YS, Lim HY, Choi DW, Kang WK, Park K, Park JO. Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma. Cancer. 109: 1561-9. PMID 17354229 DOI: 10.1002/cncr.22559  0.92
2007 Uhm JE, Lim HY, Kim WS, Choi HY, Lee HM, Park BB, Park K, Kang WK. Paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract. Neoplasia (New York, N.Y.). 9: 18-22. PMID 17325740 DOI: 10.1593/neo.06661  0.36
2007 Lee J, Kim WS, Kim K, Ahn JS, Jung CW, Lim HY, Kang WK, Park K, Ko YH, Kim YH, Park C, Yoon SH, Lee WY, Chun HK. Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leukemia Research. 31: 359-64. PMID 16930692 DOI: 10.1016/j.leukres.2006.06.018  0.92
2007 Park KW, Ahn JS, Park YS, Lee J, Kang JH, Park JO, Lim HY, Im YH, Kang WK, Park K, Lee SI. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer. Cancer Chemotherapy and Pharmacology. 59: 17-21. PMID 16721549 DOI: 10.1007/s00280-006-0253-2  0.92
2007 Kang W. Absence of magic-angle effects in the intralayer resistance Rxx of the quasi-one-dimensional organic conductor (TMTSF)2 Cl O4 Physical Review B - Condensed Matter and Materials Physics. 76. DOI: 10.1103/PhysRevB.76.193103  0.64
2006 Hong YS, Lee J, Lee SC, Hwang IG, Choi SH, Heo JS, Park JO, Park YS, Lim HY, Kang WK. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer. Cancer Chemotherapy and Pharmacology. 60: 321-8. PMID 17143602 DOI: 10.1007/s00280-006-0380-9  0.44
2006 Kim HJ, Jung CW, Kim K, Ahn JS, Kim WS, Park K, Ko YH, Kang WK, Park K. Isolated blast crisis in CNS in a patient with chronic myelogenous leukemia maintaining major cytogenetic response after imatinib. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 4028-9. PMID 16921058 DOI: 10.1200/JCO.2006.05.5608  0.6
2006 Lim do H, Lee J, Lee HG, Park BB, Peck KR, Oh WS, Ji SH, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Park YS, Im YH, Kang WK, et al. Pulmonary complications after hematopoietic stem cell transplantation. Journal of Korean Medical Science. 21: 406-11. PMID 16778380 DOI: 10.3346/jkms.2006.21.3.406  0.92
2006 Park BK, Kim YJ, Park JY, Bang S, Park SW, Chung JB, Kim KS, Choi JS, Lee WJ, Song SY. Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Journal of Gastroenterology and Hepatology. 21: 999-1003. PMID 16724985 DOI: 10.1111/j.1440-1746.2006.04230.x  0.36
2006 Lee J, Lee I, Park C, Kang WK. Lovastatin-induced RhoA modulation and its effect on senescence in prostate cancer cells. Biochemical and Biophysical Research Communications. 339: 748-54. PMID 16316623 DOI: 10.1016/j.bbrc.2005.11.075  0.32
2006 Jo YJ, Kang H, Kang W. Influence of uniaxial strain on the electronic properties of (TMTSF) 2ReO 4 compounds Journal of Low Temperature Physics. 142: 535-538. DOI: 10.1007/s10909-006-9170-3  0.64
2006 Kang W, Lee K. Optimization problems in the simulation of multifactor portfolio credit risk Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 3982: 777-784. DOI: 10.1007/11751595_82  0.96
2006 Chung Y, Kang W. Preparation of ZnO nanoparticles by laser ablation of dispersed ZnO powder in solution Journal of the Korean Chemical Society. 50: 440-446.  1
2005 Rhee JY, Park JO, Kwon GY, Nam S, Yoo BC, Park YS, Im YH, Kang WK, Park K. Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer. CASE 2. Hepatocellular carcinoma with metastasis to the breast. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8908-9. PMID 16314652 DOI: 10.1200/JCO.2005.04.1038  0.92
2005 Park BB, Kim WS, Lee J, Park KW, Kang JH, Lee SH, Park JO, Kim K, Jung CW, Park YS, Im YH, Kang WK, Ko YH, Lee MH, Park K. IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas. Leukemia & Lymphoma. 46: 1743-8. PMID 16263576 DOI: 10.1080/10428190500178266  0.88
2005 Lee J, Lee KE, Im YH, Kang WK, Park K, Kim K, Shim YM. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma. The Annals of Thoracic Surgery. 80: 1170-5. PMID 16181835 DOI: 10.1016/j.athoracsur.2005.03.058  0.92
2005 Kim S, Lim DH, Lee J, Kang WK, MacDonald JS, Park CH, Park SH, Lee SH, Kim K, Park JO, Kim WS, Jung CW, Park YS, Im YH, Sohn TS, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. International Journal of Radiation Oncology, Biology, Physics. 63: 1279-85. PMID 16099596 DOI: 10.1016/j.ijrobp.2005.05.005  0.92
2005 Park SH, Lee J, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Park YS, Kang WK, Park K, Kim S, Bang SM, Cho EK, Shin DB, Lee JH. Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 57: 91-6. PMID 16088407 DOI: 10.1007/s00280-005-0027-2  0.32
2005 Jung HH, Lee J, Kim JH, Ryu KJ, Kang SA, Park C, Sung K, Nam DH, Kang WK, Park K, Im YH. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell. Febs Letters. 579: 3941-6. PMID 15996661 DOI: 10.1016/j.febslet.2005.06.011  0.44
2005 Lee J, Park YH, Kim WS, Lee SS, Ryoo BY, Yang SH, Park KW, Kang JH, Park JO, Lee SH, Kim K, Jung CW, Park YS, Im YH, Kang WK, et al. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. European Journal of Cancer (Oxford, England : 1990). 41: 1402-8. PMID 15963893 DOI: 10.1016/j.ejca.2005.03.010  0.76
2005 Ji SH, Park YS, Lee J, Lim DH, Park BB, Park KW, Kang JH, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, Park K. Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer. Japanese Journal of Clinical Oncology. 35: 214-7. PMID 15845571 DOI: 10.1093/jjco/hyi061  0.92
2005 Lim DH, Park YS, Park BB, Ji SH, Lee J, Park KW, Kang JH, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, Park K. Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study. Cancer Chemotherapy and Pharmacology. 56: 10-4. PMID 15782313 DOI: 10.1007/s00280-004-0963-2  0.92
2004 Lim do H, Im YH, Ji SH, Park BB, Oh MJ, Lee J, Park KW, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Park YS, Kang WK, Lee MH, et al. Esophageal squamous cell carcinoma recurring as a solitary renal mass. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 36: 271-4. PMID 20368845 DOI: 10.4143/crt.2004.36.4.271  0.92
2004 Ji SH, Park JO, Lee J, Oh MJ, Lim do H, Park BB, Park KW, Lee SH, Kim K, Kim WS, Jung CW, Park YS, Im YH, Kang WK, Lee MH, et al. Three cases of synchronous solid tumor and multiple myeloma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 36: 338-40. PMID 20368825 DOI: 10.4143/crt.2004.36.5.338  0.92
2004 Park SH, Kang WK, Lee HR, Park J, Lee KE, Lee SH, Park JO, Kim K, Kim WS, Chung CW, Im YH, Lee MH, Park CH, Park K. Docetaxel plus cisplatin as second-line therapy in metastatic or recurrent advanced gastric cancer progressing on 5-fluorouracil-based regimen. American Journal of Clinical Oncology. 27: 477-80. PMID 15596914 DOI: 10.1097/01.coc.0000136018.81814.79  0.88
2004 Kim JH, Lee SH, Park J, Kim HY, Lee SI, Park JO, Kim K, Kim WS, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Park K, Han JH, et al. Primary pulmonary non-Hodgkin's lymphoma. Japanese Journal of Clinical Oncology. 34: 510-4. PMID 15466823 DOI: 10.1093/jjco/hyh095  0.88
2004 Lee J, Park JO, Kim WS, Park SH, Park KW, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Joh J, Kim K, Jung CW, Park YS, Im YH, ... Kang WK, et al. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 54: 385-90. PMID 15248028 DOI: 10.1007/s00280-004-0837-7  0.88
2004 Park J, Park BB, Kim JY, Lee SH, Lee SI, Kim HY, Kim JH, Park SH, Lee KE, Park JO, Kim K, Jung CW, Park YS, Im YH, Kang WK, et al. Gefitinib (ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 4383-8. PMID 15240526 DOI: 10.1158/1078-0432.CCR-04-0189  0.88
2004 Kim JH, Lee SH, Park J, Kim HY, Lee SI, Nam EM, Park JO, Kim K, Jung CW, Im YH, Kang WK, Lee MH, Park K. Extrapulmonary small-cell carcinoma: a single-institution experience. Japanese Journal of Clinical Oncology. 34: 250-4. PMID 15231859 DOI: 10.1093/jjco/hyh052  0.88
2004 Lee KA, Ki CS, Kim HJ, Sohn KM, Kim JW, Kang WK, Rhee JC, Song SY, Sohn TS. Novel interleukin 1β polymorphism increased the risk of gastric cancer in a Korean population Journal of Gastroenterology. 39: 429-433. PMID 15175940 DOI: 10.1007/s00535-003-1315-4  0.88
2004 Lee J, Kim WS, Kim K, Ko YH, Kim JJ, Kim YH, Chun HK, Lee WY, Park JO, Jung CW, Im YH, Lee MH, Kang WK, Park K. Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leukemia & Lymphoma. 45: 339-44. PMID 15101721 DOI: 10.1080/10428190310001593111  0.88
2004 Lee J, Park JO, Kim WS, Lee SI, Song SY, Lim DH, Choi SH, Heo JS, Lee KT, Lee JK, Kim K, Jung CW, Im YH, Lee MH, Kang WK, et al. Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer. Oncology. 66: 32-7. PMID 15031596 DOI: 10.1159/000076332  0.88
2004 Lee J, Lee MH, Kim WS, Kim K, Park SH, Lee SH, Lee KE, Park J, Park JO, Jung CW, Im YH, Kang WK, Park K. Tuberculosis in hematopoietic stem cell transplant recipients in Korea. International Journal of Hematology. 79: 185-8. PMID 15005349 DOI: 10.1532/IJH97.A10219  0.88
2004 Park SH, Lee MH, Lee SH, Lee KE, Park J, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, Park K, Kim SW, Lee KH, Lee JH. The Outcomes of Hypertransfusion in Major ABO Incompatible Allogeneic Stem Cell Transplantation Journal of Korean Medical Science. 19: 79-82. PMID 14966346 DOI: 10.3346/jkms.2004.19.1.79  0.88
2004 Kang W. Magnetoresistance study of low-dimensional electrons in the Bechgaard salts Current Applied Physics. 4: 263-266. DOI: 10.1016/j.cap.2003.11.024  0.64
2003 Park KW, Im YH, Lee J, Kim E, Lee H, Song BG, Park JO, Kim K, Jung CW, Park YS, Kang WK, Lee MH, Park K. Use of GCDFP-15 (BRST-2) as a Specific Immunocytochemical Marker for Diagnosis of Gastric Metastasis of Breast Carcinoma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 35: 460-4. PMID 26680974 DOI: 10.4143/crt.2003.35.5.460  0.92
2003 Lee SH, Ahn YC, Kim HJ, Lim DH, Lee SI, Nam E, Park SH, Park J, Lee KE, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, et al. Early concurrent chemoradiotherapy with prolonged oral etoposide and cisplatin for limited-stage small-cell lung cancer. Japanese Journal of Clinical Oncology. 33: 620-5. PMID 14769839 DOI: 10.1093/jjco/hyg115  0.88
2003 Park JO, Lee SI, Song SY, Kim K, Kim WS, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Lee KS, Park K. Measuring response in solid tumors: Comparison of RECIST and WHO response criteria Japanese Journal of Clinical Oncology. 33: 533-537. PMID 14623923 DOI: 10.1093/jjco/hyg093  0.88
2003 Park J, Ahn YC, Kim H, Lee SH, Park SH, Lee KE, Lim DH, Park J, Kim K, Jung CW, Im YH, Kang WK, Lee MH, Park K. A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers. Lung Cancer (Amsterdam, Netherlands). 42: 227-35. PMID 14568691 DOI: 10.1016/S0169-5002(03)00282-4  0.88
2003 Song SY, Kim WS, Lee HR, Jung HS, Oh SY, Kim JH, Kim K, Nam EM, Oh YR, Jung CW, Yoon SS, Im YH, Lee HG, Kang WK, Park CH, et al. Adenocarcinoma of unknown primary site. The Korean Journal of Internal Medicine. 17: 234-9. PMID 12647637 DOI: 10.3904/kjim.2002.17.4.234  0.4
2002 Park WH, Seol JG, Kim ES, Kang WK, Im YH, Jung CW, Kim BK, Lee YY. Monensin-mediated growth inhibition in human lymphoma cells through cell cycle arrest and apoptosis. British Journal of Haematology. 119: 400-7. PMID 12406077 DOI: 10.1046/j.1365-2141.2002.03834.x  0.88
2002 Kim K, Lee MH, Kim J, Lee KS, Kim SM, Jung MP, Han J, Sung KW, Kim WS, Jung CW, Yoon SS, Im YH, Kang WK, Park K, Park CH. Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. American Journal of Hematology. 71: 75-9. PMID 12353303 DOI: 10.1002/ajh.10168  0.88
2002 Bang YJ, Kang WK, Kang YK, Kim HC, Jacques C, Zuber E, Daglish B, Boudraa Y, Kim WS, Heo DS, Kim NK. Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial. Japanese Journal of Clinical Oncology. 32: 248-54. PMID 12324575 DOI: 10.1093/jjco/hyf057  0.88
2002 Kim K, Nam E, Lee NS, Lee HR, Lee JY, Lee HR, Park SH, Oh SY, Kim JH, Song SY, Park JO, Kim WS, Jung CW, Im YH, Lee MH, ... ... Kang WK, et al. Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer. American Journal of Clinical Oncology. 25: 354-7. PMID 12151964 DOI: 10.1097/00000421-200208000-00007  0.88
2002 Lee HG, Park EY, Kim HM, Kim K, Kim WS, Yoon SS, Kang WK, Park KC, Park CH. Sexuality and quality of life after hematopoietic stem cell transplantation. The Korean Journal of Internal Medicine. 17: 19-23. PMID 12014208 DOI: 10.3904/kjim.2002.17.1.19  0.44
2002 Kim K, Kim WS, Jung CW, Im YH, Kang WK, Lee MH, Park CH, Ko YH, Ree HJ, Park K. Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification European Journal of Cancer. 38: 75-81. PMID 11750843 DOI: 10.1016/S0959-8049(01)00344-6  0.88
2002 Kang W, Lee NH. Mathematical modeling to predict drying deformation and stress due to the differential shrinkage within a tree disk Wood Science and Technology. 36: 463-476. DOI: 10.1007/s00226-002-0153-5  0.36
2001 Kim WS, Kim MM, Choi HJ, Yoon SS, Lee MH, Park K, Park CH, Kang WK. Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma Investigational New Drugs. 19: 81-83. PMID 11291836 DOI: 10.1023/A:1006481423298  0.88
2000 Kim J, Kang W. Use of graphite plate for homogeneous sample preparation in matrix/surface-assisted laser desorption and ionization of polypropyleneglycol and polystyrene Bulletin of the Korean Chemical Society. 21: 401-404.  1
1996 Kim SH, Kang W. Culture method to enhance the productivity of hepatitis B surface antigen (pre S2 + S Ag) with recombinant Saccharomyces cerevisiae Biotechnology Techniques. 10: 233-238.  0.4
1995 Kang W, Park SA. Electric field dependent transport in the quantized hall states of (TMTSF)2ClO4 Synthetic Metals. 70: 757-758. DOI: 10.1016/0379-6779(94)02640-K  0.64
1993 Kang W. Splitting mechanism of the quantum oscillations in the quasi-two dimensional conductors Synthetic Metals. 57: 4666-4671. DOI: 10.1016/0379-6779(93)90800-C  0.64
1991 Kang W. On the splitting of Shubnikov-de Haas oscillations in organic conductors Solid State Communications. 78: 25-28. DOI: 10.1016/0038-1098(91)90802-3  0.64
Show low-probability matches.